+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lupus Nephritis"

Lupus Nephritis Market Report 2025 - Product Thumbnail Image

Lupus Nephritis Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
Rare Kidney Diseases Market Report 2025 - Product Thumbnail Image

Rare Kidney Diseases Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Rare Kidney Diseases Market Report and Forecast 2025-2034 - Product Thumbnail Image

Rare Kidney Diseases Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Polycystic Kidney Disease Market - Product Thumbnail Image

Polycystic Kidney Disease Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
Nephrology Secrets: First South Asia Edition - Product Thumbnail Image

Nephrology Secrets: First South Asia Edition

  • Book
  • August 2018
  • Asia Pacific
Chronic Renal Disease. Edition No. 2 - Product Thumbnail Image

Chronic Renal Disease. Edition No. 2

  • Book
  • November 2019
  • 14 Results (Page 1 of 1)
Loading Indicator

Lupus Nephritis is a type of kidney disease caused by systemic lupus erythematosus (SLE). It is a common complication of SLE and is one of the leading causes of end-stage renal disease. In the context of Urology and Nephrology, Lupus Nephritis is a major area of research and treatment. It is a complex condition that requires a multidisciplinary approach, including nephrologists, rheumatologists, and other specialists. Treatment options include immunosuppressive medications, such as corticosteroids, and biologic agents. In some cases, kidney transplantation may be necessary. Companies in the Lupus Nephritis market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis, Pfizer, and Roche. Show Less Read more